Strategies for understanding and reducing the Plasmodium vivax and Plasmodium ovale hypnozoite reservoir in Papua New Guinean children: a randomised placebo-controlled trial and mathematical model
about
Changes in malaria burden and transmission in sentinel sites after the roll-out of long-lasting insecticidal nets in Papua New GuineaThe role of early detection and treatment in malaria eliminationMathematical Modelling to Guide Drug Development for Malaria EliminationImplications of Plasmodium vivax Biology for Control, Elimination, and ResearchCosts and Cost-Effectiveness of Plasmodium vivax ControlVariation in Human Cytochrome P-450 Drug-Metabolism Genes: A Gateway to the Understanding of Plasmodium vivax RelapsesThe Vivax Surveyor: Online mapping database for Plasmodium vivax clinical trialsA systematic review of the clinical presentation, treatment and relapse characteristics of human Plasmodium ovale malariaPlasmodium cynomolgi infections in rhesus macaques display clinical and parasitological features pertinent to modelling vivax malaria pathology and relapse infectionsDefining the next generation of Plasmodium vivax diagnostic tests for control and elimination: Target product profiles.Antibody Responses to Plasmodium falciparum and Plasmodium vivax and Prospective Risk of Plasmodium spp. Infection Postpartum.Synergistic effect of IL-12 and IL-18 induces TIM3 regulation of γδ T cell function and decreases the risk of clinical malaria in children living in Papua New GuineaMalaria control by commodities without practical malariology.Asia-Pacific malaria is singular, pervasive, diverse and invisibleAn Antibody Screen of a Plasmodium vivax Antigen Library Identifies Novel Merozoite Proteins Associated with Clinical Protection.Submicroscopic and Asymptomatic Plasmodium Parasitaemia Associated with Significant Risk of Anaemia in Papua, IndonesiaAcquisition and Longevity of Antibodies to Plasmodium vivax Preerythrocytic Antigens in Western Thailand.Declining malaria transmission in rural Amazon: changing epidemiology and challenges to achieve elimination.Anti-malarial seroprevalence assessment during an elimination programme in Chabahar District, south-eastern Iran.Key Knowledge Gaps for Plasmodium vivax Control and EliminationUnsupervised primaquine for the treatment of Plasmodium vivax malaria relapses in southern Papua: A hospital-based cohort study.Higher Complexity of Infection and Genetic Diversity of Plasmodium vivax Than Plasmodium falciparum Across All Malaria Transmission Zones of Papua New Guinea.Prevention and control of malaria in pregnancy - new threats, new opportunities?The complex relationship of exposure to new Plasmodium infections and incidence of clinical malaria in Papua New GuineaInfectivity of symptomatic and asymptomatic Plasmodium vivax infections to a Southeast Asian vector, Anopheles dirus.The Incidence and Differential Seasonal Patterns of Plasmodium vivax Primary Infections and Relapses in a Cohort of Children in Papua New GuineaEffects of liver-stage clearance by Primaquine on gametocyte carriage of Plasmodium vivax and P. falciparum.Naturally acquired antibody responses to more than 300 Plasmodium vivax proteins in three geographic regions.Population-level estimates of the proportion of Plasmodium vivax blood-stage infections attributable to relapses among febrile patients attending Adama Malaria Diagnostic Centre, East Shoa Zone, Oromia, Ethiopia.The Biology of Plasmodium vivax.[Role of primaquine in malaria control and elimination in French-speaking Africa].Theoretical Implications of a Pre-Erythrocytic Plasmodium vivax Vaccine for Preventing Relapses.Identification of highly-protective combinations of Plasmodium vivax recombinant proteins for vaccine development.Sustained Malaria Control Over an 8-Year Period in Papua New Guinea: The Challenge of Low-Density Asymptomatic Plasmodium Infections.Functional conservation of the AMA1 host-cell invasion ligand between P. falciparum and P. vivax: a novel platform to accelerate vaccine and drug development.malERA: An updated research agenda for combination interventions and modelling in malaria elimination and eradication.malERA: An updated research agenda for diagnostics, drugs, vaccines, and vector control in malaria elimination and eradication.Cost-effectiveness of artemisinin-naphthoquine versus artemether-lumefantrine for the treatment of uncomplicated malaria in Papua New Guinean children.malERA: An updated research agenda for characterising the reservoir and measuring transmission in malaria elimination and eradication.Insecticide-treated nets and malaria prevalence, Papua New Guinea, 2008-2014.
P2860
Q26315315-04029D1E-859C-4656-8FC1-EFDD9E30D874Q26740068-70094B20-C8F6-4512-989E-82F71EBBD057Q28067367-A80F4D80-7B2C-45CD-8D65-E907C6F144B0Q28355362-37C5DACE-0EAF-4964-968A-80400C82621FQ28355704-E2F3470B-5052-41CC-B953-905F3EDE1E60Q28553162-C7D6EF58-FB04-4B66-970D-A8D3B4E9EEA5Q30491343-93A6BEC7-7CFF-412E-90DA-75A8F7E58510Q30841521-A81AEC5B-ABDF-43C6-9A6F-A8B4348A344FQ33435123-22CC8D7F-3E0E-4BD8-8546-8475AD99EE0FQ33563151-9278AA02-4AA9-4448-8B18-472CBED16ADCQ33636850-DBABA216-4473-4D0B-A20F-B5BEDDBF7988Q33802385-0C19A4F7-8E08-4E0A-9569-DC28AB0A20EDQ33823424-AD25854A-1615-441A-802D-69DB391ADA7CQ33828552-9CA215D3-EF21-4F8F-AC89-4C222769A70AQ36018397-D43FF71C-9FA3-4828-9029-87880F705DC8Q36176399-0997B172-BC48-41CA-9CDA-D8406DFB8C48Q36555051-2A5C53FB-BAF1-4258-8CFD-613DC2732ECCQ36890529-EED1E271-671D-4981-B7C0-61BE6E5C2D62Q37119475-AD57BBEA-6C1A-4711-A75B-0FCA4CC598C9Q37546198-F3767CBA-0600-48D3-8A85-D36F5EF8780AQ38603812-8CED0EFA-295A-40FB-B19E-206B52565685Q39007254-59D97801-E0AE-4F6F-9DFF-0DB7C184DFF3Q39038490-7DEE9994-4AB5-4CBE-8D7C-67D8E4C038A8Q39071168-13E8A76A-B04D-468B-AED8-80FCD708F098Q39135098-C2A42A8B-F412-4667-B4EB-48D6209DFC78Q39409632-93FA772F-2601-4FDA-868B-4FAFE9D8328AQ39571844-92D87E9A-B614-4471-8CE2-DB4282A67AAEQ40047662-D1956264-5069-429D-BF87-F5857396E93FQ40105373-2E0C20E7-2E23-4615-ABDE-22C24D7792F4Q40218474-2DEB4737-C356-49C4-A834-E330696947F5Q40247802-8FB7660A-8B29-4510-8502-A2E93E228703Q40376176-009D8B33-8E4E-45C1-AED8-0D27748469C4Q41994105-CCBD563E-EC34-4EA5-A89A-90EF3A97C5A6Q45972140-B8F2122C-1902-499C-A364-B18ADCDD5402Q46256154-671DD04B-D321-4807-81FB-E856725B8A54Q47132201-A844CC66-BEFB-495E-B071-C2132938D0BAQ47134819-953E71B1-E192-4A62-8E31-535CA60EF73CQ47143596-4BECCD67-68F7-4030-8D70-40AFDBD2BB30Q47157140-6DA1A521-3866-4AA4-BDCA-D94658C536C6Q47163342-3B46BAFD-EA75-4B13-AD81-06E0DE2CA102
P2860
Strategies for understanding and reducing the Plasmodium vivax and Plasmodium ovale hypnozoite reservoir in Papua New Guinean children: a randomised placebo-controlled trial and mathematical model
description
2015 nî lūn-bûn
@nan
2015 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Strategies for understanding a ...... d trial and mathematical model
@ast
Strategies for understanding a ...... d trial and mathematical model
@en
Strategies for understanding a ...... d trial and mathematical model
@nl
type
label
Strategies for understanding a ...... d trial and mathematical model
@ast
Strategies for understanding a ...... d trial and mathematical model
@en
Strategies for understanding a ...... d trial and mathematical model
@nl
prefLabel
Strategies for understanding a ...... d trial and mathematical model
@ast
Strategies for understanding a ...... d trial and mathematical model
@en
Strategies for understanding a ...... d trial and mathematical model
@nl
P2093
P2860
P50
P921
P3181
P1433
P1476
Strategies for understanding a ...... d trial and mathematical model
@en
P2093
Andreea Waltmann
Benson Kinboro
Connie S N Li Wai Suen
Inoni Betuela
Jessica Brewster
Leanne J Robinson
Lina Lorry
Lornah Samol
Mariabeth Silkey
Nandao Tarongka
P2860
P304
P356
10.1371/JOURNAL.PMED.1001891
P407
P577
2015-10-01T00:00:00Z